Winn Wins - Latest News on FIP Research

Winn's Weekly Feline Research Byte The Latest News on FIP Research, the Bria Fund and Winn Feline Foundation A recent media release announced licensure and commercial development of GC376, an antiviral FIP drug demonstrated to cure some cats with FIP. The research on the drug was coordinated between Dr. Yunjeong Kim of Kansas State University and Dr. Niels Pedersen of University of California-Davis. Because of the research results, the Kansas State University of Commercialization coordinated a licensing agreement with Anivive Lifesciences, a California company with proprietary software able to advance discovery and development of new pet medications. While GC376 is still several years from r

© 2020  by Bria Fund ™ Supporters for FIP Research

  • Groups.io
  • Black Facebook Icon
  • Black Twitter Icon